Company intelligence / Profile preview

CareTelCom

Veberöd/Lund, Skåne, Swedenpmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Preclinical

Overview

CareTelCom AB develops concepts and systems to improve prevention and care for people with chronic diseases. Their initial products, CTC Actiwise and CTC Actiwise Predict, focus on COPD management using artificial intelligence. The company emphasizes simplicity, ease of use, cost efficiency, and bases its applications on established medical science. No clinical trial results or commercial launches are reported; the technology appears to be at prototype stage.

Therapeutic areas: PulmonologyOther
Modalities: DeviceDigital health solutionArtificial Intelligence-based software tools
Industry: Digital Health Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships disclosed.

Beyond the preview

Go deeper on CareTelCom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CareTelCom.

Explore the full profile